These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20020496)

  • 1. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer.
    Nakamura J; Kitajima Y; Kai K; Mitsuno M; Ide T; Hashiguchi K; Hiraki M; Miyazaki K
    Oncol Rep; 2009 Oct; 22(4):693-9. PubMed ID: 19724845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.
    Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
    Int J Cancer; 2011 Apr; 128(8):1935-45. PubMed ID: 20560137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in gastric carcinoma].
    Wu Q; Li ZS; Li DW; Peng ZH; Yang ZR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):498-501. PubMed ID: 19742344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy.
    Lee J; Park CK; Park JO; Lim T; Park YS; Lim HY; Lee I; Sohn TS; Noh JH; Heo JS; Kim S; Lim DH; Kim KM; Kang WK
    Clin Cancer Res; 2008 Jan; 14(1):82-8. PubMed ID: 18172256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
    Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
    Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
    Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
    Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypoxia on HIF
    Wang L; Xing W; Qi J; Lu Y; Xiang L; Zhou Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1629-1636. PubMed ID: 36748372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.
    Huang Y; Yu H; Lei H; Xie C; Zhong Y
    Med Oncol; 2014 Mar; 31(3):824. PubMed ID: 24469951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
    Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
    Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.
    Qiu MZ; Han B; Luo HY; Zhou ZW; Wang ZQ; Wang FH; Li YH; Xu RH
    Tumour Biol; 2011 Feb; 32(1):159-66. PubMed ID: 20845004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.